Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Shares Issued: 2020-2025

  • Janux Therapeutics' Shares Issued fell 45.62% to $901,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $3.3 million, marking a year-over-year increase of 37.87%. This contributed to the annual value of $204.2 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Janux Therapeutics reported Shares Issued of $901,000 as of Q1 2025, which was down 45.62% from $1.7 million recorded in Q1 2024.
  • In the past 5 years, Janux Therapeutics' Shares Issued ranged from a high of $1.7 million in Q1 2024 and a low of -$843,000 during Q3 2021.
  • In the last 3 years, Janux Therapeutics' Shares Issued had a median value of $1.6 million in 2023 and averaged $1.4 million.
  • Per our database at Business Quant, Janux Therapeutics' Shares Issued rose by 4.87% in 2024 and then crashed by 45.62% in 2025.
  • Over the past 4 years, Janux Therapeutics' Shares Issued (Quarterly) stood at -$843,000 in 2021, then reached $1.6 million in 2023, then rose by 4.87% to $1.7 million in 2024, then plummeted by 45.62% to $901,000 in 2025.
  • Its Shares Issued stands at $901,000 for Q1 2025, versus $1.7 million for Q1 2024 and $1.6 million for Q1 2023.